BioNTech SE (BNTX)
NASDAQ: BNTX · IEX Real-Time Price · USD
86.17
-0.23 (-0.27%)
At close: Apr 18, 2024, 4:00 PM
86.20
+0.03 (0.03%)
After-hours: Apr 18, 2024, 7:45 PM EDT
BioNTech SE Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for BioNTech SE stock have an average target of 127.58, with a low estimate of 90 and a high estimate of 203. The average target predicts an increase of 48.06% from the current stock price of 86.17.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for BioNTech SE stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 6 | 6 | 5 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 8 | 7 | 7 | 6 | 6 | 5 |
| Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 14 | 14 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $107 | Strong Buy | Reiterates | $107 | +24.17% | Apr 17, 2024 |
| UBS | UBS | Hold Maintains $110 → $101 | Hold | Maintains | $110 → $101 | +17.21% | Mar 27, 2024 |
| JP Morgan | JP Morgan | Sell Maintains $99 → $90 | Sell | Maintains | $99 → $90 | +4.44% | Mar 22, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $127 → $123 | Buy | Maintains | $127 → $123 | +42.74% | Mar 21, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Reiterates $171 | Strong Buy | Reiterates | $171 | +98.44% | Mar 21, 2024 |
Financial Forecast
Revenue This Year
2.87B
from 3.82B
Decreased by -24.74%
Revenue Next Year
2.91B
from 2.87B
Increased by 1.36%
EPS This Year
-1.76
from 3.83
EPS Next Year
-1.35
from -1.76
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.1B | 3.9B | 4.5B | 7.2B | 8.2B |
| Avg | 2.9B | 2.9B | 3.0B | 4.5B | 5.4B |
| Low | 2.2B | 2.0B | 1.8B | 3.3B | 3.9B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 8.5% | 36.9% | 53.0% | 139.2% | 84.5% |
| Avg | -24.7% | 1.4% | 2.8% | 49.0% | 21.8% |
| Low | -41.7% | -28.8% | -38.9% | 9.9% | -12.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.16 | 4.41 | 4.74 | 5.75 | 7.70 |
| Avg | -1.76 | -1.35 | -0.84 | 2.87 | 4.15 |
| Low | -3.65 | -5.61 | -6.03 | -2.58 | -0.30 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -43.5% | - | - | - | 168.5% |
| Avg | - | - | - | - | 44.8% |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.